首页>
外国专利>
SIVmac239 Immunogenic Plasmids, Recombinant adenoviral vectors, and Immunization protocol using the same that reduce viral loads after mucosal SIVmac239 infection
SIVmac239 Immunogenic Plasmids, Recombinant adenoviral vectors, and Immunization protocol using the same that reduce viral loads after mucosal SIVmac239 infection
A DNA vaccine composition and a recombinant adenovirus vaccine composition using an SIVmac239/rhesus macaque model are provided to show excellent AIDS virus infection prophylactic and therapeutic effect when being applied to a priming-boosting technique, thereby being used as a novel agent for preventing and treating the AIDS. A priming vaccine composition for preventing or treating AIDS comprises: (a) an immunogenic plasmid including an SIV Gag gene and an Env gene; and (b) an immunogenic plasmid including a gene codon-optimized by nef-tat-vpx-vif-tat. A boosting vaccine composition for preventing or treating AIDS comprises: (a) a recombinant adenovirus including an SIV Gag gene and an Env gene; and (b) a recombinant adenovirus including an sVif-Nef gene and an sTat-Vpx gene. A vaccine kit for preventing or treating AIDS comprises the priming vaccine composition and the boosting vaccine composition. Further, the priming vaccine composition for preventing or treating AIDS additionally comprises a PLGA(poly lactic-co-glycolic acid)-Y peptide.
展开▼